Back to results
US 6,441,032 B1Granted
Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical use
AssigneeCentaur Pharmaceuticals, Inc.
InventorsJudith A. Kelleher, Kirk R. Maples, Alina Dykman, Yong-Kang Zhang, Allan L. Wilcox, Julian Levell
Life of this patent
Estimating the term…
Abstract
Disclosed are novel α-aryl-N-alkylnitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals and as analytical reagents for detecting free radicals.
Claims8
α-(4-Ethoxyphenyl)-N-tert-butylnitrone.
A pharmaceutical composition comprising α-(4-ethoxyphenyl)-N-tert-butylnitrone in a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.